Jonathan Chick
Research Subjects
Research Interests
Jonathan Chick has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Colin Drummond
National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London
1 shared publication - David J. Nutt
Imperial College London
1 shared publication Elin Heldbo Reines
H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark
1 shared publication- Fiona Sim
Independent Medical Advisory Panel to the Drinkaware Trust, Salisbury House, London EC2M 5SQ, UK
1 shared publication - Florence Tubach
Sorbonne Université, INSERM, Sorbonne Public Health Institute, Team PEPITES, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique , F75013 Paris
1 shared publication Frank Andersohn
Frank Andersohn Consulting and Research Services, Mandelstr. 16, 10409 Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 1 July 2021
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 56 (5) , 556-564
Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
Two post-authorisation studies assessed the safety and persistence of patients’ use of nalmefene. The START study (EUPAS5678) was a non-interventional, multi-country, prospective, 18-month (8 follow-up visits) cohort study including outpatients initiating nalmefene for the first time. The multi-database retrospective cohort study (MDRC, EUPAS14083) included baseline and follow-up data from German, Swedish and UK healthcare databases. Both studies permitted ‘all comers’ without explicit exclusion criteria; predefined subgroups of interest included the elderly (≥65 years) as well as patients with significant psychiatric and/or somatic comorbidities. START study: Overall, the mean duration of nalmefene treatment was 10.3 ± 7.3 months (N = 1348), with 49.0% of patients treated for ≥1 year; frequent reasons for treatment discontinuation were ‘goal reached’ and ‘drug cost’. The most frequently reported adverse drug reactions (ADRs) were nausea (4.7%), dizziness (3.2%) and insomnia (2.0%). ADR rates appeared higher in the elderly subpopulation (18.6% reported ≥1 ADR vs. 12.0% in the total population) but were not higher in the other predefined subgroups. MDRC study: The database follow-up analysis followed 2892 patients over 18 months for whom the duration of nalmefene treatment was between 2 and 3 months and <5% of patients used nalmefene for ≥1 year. Despite the inclusion of a wider patient population (e.g. elderly patients and those with relevant co-morbidities), the safety and tolerability profile of nalmefene given in routine practice was consistent with previous clinical studies. The differing rates of persistence beyond 1 year likely reflect the different methodologies and highlight the relevance of psychosocial support at follow-up visits.
- 1 July 2021
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 56 (5) , 556-564
Open AccessSafety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
Two post-authorisation studies assessed the safety and persistence of patients’ use of nalmefene. The START study (EUPAS5678) was a non-interventional, multi-country, prospective, 18-month (8 follow-up visits) cohort study including outpatients initiating nalmefene for the first time. The multi-database retrospective cohort study (MDRC, EUPAS14083) included baseline and follow-up data from German, Swedish and UK healthcare databases. Both studies permitted ‘all comers’ without explicit exclusion criteria; predefined subgroups of interest included the elderly (≥65 years) as well as patients with significant psychiatric and/or somatic comorbidities. START study: Overall, the mean duration of nalmefene treatment was 10.3 ± 7.3 months (N = 1348), with 49.0% of patients treated for ≥1 year; frequent reasons for treatment discontinuation were ‘goal reached’ and ‘drug cost’. The most frequently reported adverse drug reactions (ADRs) were nausea (4.7%), dizziness (3.2%) and insomnia (2.0%). ADR rates appeared higher in the elderly subpopulation (18.6% reported ≥1 ADR vs. 12.0% in the total population) but were not higher in the other predefined subgroups. MDRC study: The database follow-up analysis followed 2892 patients over 18 months for whom the duration of nalmefene treatment was between 2 and 3 months and <5% of patients used nalmefene for ≥1 year. Despite the inclusion of a wider patient population (e.g. elderly patients and those with relevant co-morbidities), the safety and tolerability profile of nalmefene given in routine practice was consistent with previous clinical studies. The differing rates of persistence beyond 1 year likely reflect the different methodologies and highlight the relevance of psychosocial support at follow-up visits.
- Open Access
- 13 May 2020
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 55 (4) , 341-342
Alcohol and COVID-19
When there is an epidemic, rumours proliferate about protective nostrums. Various tropical islands and even Manhattan changed hands due to wars and treaties involving nutmeg, which was promoted in Europe as a protection against bubonic plague. Suddenly, in 2020, the price of turmeric increased in South Asia and Indonesia because of the coronavirus pandemic ( CNA News, 2020; India Times, 2020).
- 13 May 2020
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 55 (4) , 341-342
Open AccessAlcohol and COVID-19
When there is an epidemic, rumours proliferate about protective nostrums. Various tropical islands and even Manhattan changed hands due to wars and treaties involving nutmeg, which was promoted in Europe as a protection against bubonic plague. Suddenly, in 2020, the price of turmeric increased in South Asia and Indonesia because of the coronavirus pandemic ( CNA News, 2020; India Times, 2020).
- Open Access
- 1 January 2020
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 55 (4) , 456
Mastering the Clinical Conversation: Language as Intervention
This theory-based—but practical—manual was well reviewed when first published in 2016.
- 1 January 2020
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 55 (4) , 456
Open AccessMastering the Clinical Conversation: Language as Intervention
This theory-based—but practical—manual was well reviewed when first published in 2016.
- Open Access
- 8 July 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (13) , 2421
Comment on MaaniHessari, N.; van Schalkwyk, M.C.; Thomas, S.; Petticrew, M. Alcohol Industry CSR Organisations: What Can Their Twitter Activity Tell Us about Their Independence and Their Priorities? A Comparative Analysis. Int. J. Environ. Res. Public Health 2019, 16, 892
We noted with concern that you published recently (12 March 2019) an article about so-called “Alcohol industry CSR Organisations”, which selectively targets criticism of Drinkaware
- 8 July 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (13) , 2421
Open AccessComment on MaaniHessari, N.; van Schalkwyk, M.C.; Thomas, S.; Petticrew, M. Alcohol Industry CSR Organisations: What Can Their Twitter Activity Tell Us about Their Independence and Their Priorities? A Comparative Analysis. Int. J. Environ. Res. Public Health 2019, 16, 892
We noted with concern that you published recently (12 March 2019) an article about so-called “Alcohol industry CSR Organisations”, which selectively targets criticism of Drinkaware
- 1 November 2017
- Published by Springer Nature
- p. 177-187
Management of Eating Disorders When There Is Also Substance Misuse
- 1 November 2017
- Published by Springer Nature
- p. 177-187
Management of Eating Disorders When There Is Also Substance Misuse
- Open Access
- 1 July 2017
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 211 (1) , 52-53
Does prescribing psychiatric medication really make it less likely that alcohol is involved in a self-poisoning?
Western depression is not a universal condition Thornicroft et al 1 assume that `mental disorder' is an entity essentially lying outside situation, society and culture, which is identifiable anywhere using a common (Western) methodology such as the Composite International Diagnostic Interview (CIDI). Biologically triumphalist studies like this simply have to be challenged, because once something ± in this case, depression as a unitary pathological entity arising naturalistically anywhere in the world ± is declared real, it becomes real in its consequences. The authors cite at the outset the World Health Organization (WHO) claim that depression is the first or second most burdensome disease, disability-wise, in the world. To me this is perhaps the most bizarre statement to come out of a major medical institution in the modern era: more burdensome than AIDS or tuberculosis, which each take around 1.5 million lives per year, and with millions more disabled over the years? The disability-adjusted life-years metric (DALY) on which the WHO claim rests is epistemologically lamentable when applied in this way. The CIDI is described by the WHO as a survey instrument produced for standard use across cultures. This does not mean it is valid. The authors concede that `no attempt was made to go beyond DSM-IV criteria to assess depression-equivalents that might be unique to specific countries' , and that `the reliability and validity of diagnoses made with the WMH CIDI may vary across countries'. This doesn't appear to deter the authors, yet it renders their conclusions risible. Western psychiatric templates simply cannot generate a universally valid knowledge base, since they fail the core test of validity, which relates to the `nature of reality' of subjects under study. Invalid approaches cannot be redeemed by `reliability' ± using a standard, reproducible method ± since the very ground they stand on is unsound. 2 This is hardly surprising since, organic categories aside, diagnoses are merely descriptive constructions, conceptual devices, and are drawn up by us, not by nature. Ironically there is a WHO study, reported by Sir David Goldberg and colleagues, which showed that in 15 cities around the world those people recognised as depressed by doctors did no better (indeed they did slightly worse) than comparable others who were not so recognised. 3 Depression has no exact equivalent in non-Western cultures, not least because these do not share a Western ethnopsychology that defines `emotion' as internal, often biological, unintentioned, distinct from cognition, and a feature of individuals rather than situations. 4 Here we see the Western psychological discourse
- 1 July 2017
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 211 (1) , 52-53
Open AccessDoes prescribing psychiatric medication really make it less likely that alcohol is involved in a self-poisoning?
Western depression is not a universal condition Thornicroft et al 1 assume that `mental disorder' is an entity essentially lying outside situation, society and culture, which is identifiable anywhere using a common (Western) methodology such as the Composite International Diagnostic Interview (CIDI). Biologically triumphalist studies like this simply have to be challenged, because once something ± in this case, depression as a unitary pathological entity arising naturalistically anywhere in the world ± is declared real, it becomes real in its consequences. The authors cite at the outset the World Health Organization (WHO) claim that depression is the first or second most burdensome disease, disability-wise, in the world. To me this is perhaps the most bizarre statement to come out of a major medical institution in the modern era: more burdensome than AIDS or tuberculosis, which each take around 1.5 million lives per year, and with millions more disabled over the years? The disability-adjusted life-years metric (DALY) on which the WHO claim rests is epistemologically lamentable when applied in this way. The CIDI is described by the WHO as a survey instrument produced for standard use across cultures. This does not mean it is valid. The authors concede that `no attempt was made to go beyond DSM-IV criteria to assess depression-equivalents that might be unique to specific countries' , and that `the reliability and validity of diagnoses made with the WMH CIDI may vary across countries'. This doesn't appear to deter the authors, yet it renders their conclusions risible. Western psychiatric templates simply cannot generate a universally valid knowledge base, since they fail the core test of validity, which relates to the `nature of reality' of subjects under study. Invalid approaches cannot be redeemed by `reliability' ± using a standard, reproducible method ± since the very ground they stand on is unsound. 2 This is hardly surprising since, organic categories aside, diagnoses are merely descriptive constructions, conceptual devices, and are drawn up by us, not by nature. Ironically there is a WHO study, reported by Sir David Goldberg and colleagues, which showed that in 15 cities around the world those people recognised as depressed by doctors did no better (indeed they did slightly worse) than comparable others who were not so recognised. 3 Depression has no exact equivalent in non-Western cultures, not least because these do not share a Western ethnopsychology that defines `emotion' as internal, often biological, unintentioned, distinct from cognition, and a feature of individuals rather than situations. 4 Here we see the Western psychological discourse
- Open Access
- 5 March 2016
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 51 (4) , 504
Poetry Changes Lives
- 5 March 2016
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 51 (4) , 504
Open AccessPoetry Changes Lives
- Open Access
- 5 May 2015
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 50 (4) , 377-378
Suicide, Self-Mutilation and Delirium Tremens
Last winter in the UK, a young man was found dead in a blood-soaked hotel bathroom. The inquest determined that he had died by his own hand. It emerged that, in a confused state, he had tried to alert staff where he was accommodated to his fears that he was unwell, but seems to have been disregarded as a drunk causing a nuisance.
- 5 May 2015
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 50 (4) , 377-378
Open AccessSuicide, Self-Mutilation and Delirium Tremens
Last winter in the UK, a young man was found dead in a blood-soaked hotel bathroom. The inquest determined that he had died by his own hand. It emerged that, in a confused state, he had tried to alert staff where he was accommodated to his fears that he was unwell, but seems to have been disregarded as a drunk causing a nuisance.
- Open Access
- 2 December 2014
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 50 (1) , 103
Recovery: Twelve Simple Steps to Life Beyond Addiction
That AA has continued to grow over 80 years is in part attributable to the wise adherence to its ‘Concepts’ and ‘Traditions’, as well as its determined financia
- 2 December 2014
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 50 (1) , 103
Open AccessRecovery: Twelve Simple Steps to Life Beyond Addiction
That AA has continued to grow over 80 years is in part attributable to the wise adherence to its ‘Concepts’ and ‘Traditions’, as well as its determined financia
- Open Access
- 23 March 2012
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 47 (3) , 365
Portrait of the Psychiatrist as a Young Man: the Early Writing and Works of R.D. Laing, 1927-1960
- 23 March 2012
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 47 (3) , 365
Open AccessPortrait of the Psychiatrist as a Young Man: the Early Writing and Works of R.D. Laing, 1927-1960